dihydroergotamine has been researched along with Movement Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evans, RW; Jankovic, J; Wijemanne, S | 1 |
| Lucker, C; Mathew, NT; Tietjen, GE | 1 |
2 other study(ies) available for dihydroergotamine and Movement Disorders
| Article | Year |
|---|---|
Movement Disorders From the Use of Metoclopramide and Other Antiemetics in the Treatment of Migraine.
Topics: Adult; Dihydroergotamine; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Expert Testimony; Female; Humans; Metoclopramide; Migraine Disorders; Movement Disorders | 2016 |
Serotonin syndrome complicating migraine pharmacotherapy.
Topics: Adult; Autonomic Nervous System Diseases; Dihydroergotamine; Drug Synergism; Female; Gastrointestinal Diseases; Humans; Injections, Intravenous; Injections, Subcutaneous; Lithium; Mental Disorders; Migraine Disorders; Movement Disorders; Serotonin Receptor Agonists; Sumatriptan; Syndrome | 1996 |